Prevention of multiple sclerosis: A realistic goal?

被引:0
作者
Vukusic, S. [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Serv Neurol A, F-69677 Lyon, France
[2] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Fdn Eugene Dev EDMUS Sclerose Plaques, F-69677 Lyon, France
[3] Equipe Neurooncol & Neuroinflammat, Ctr Neurosci Lyon, Inserm U1028, F-69003 Lyon, France
[4] Equipe Neurooncol & Neuroinflammat, Ctr Neurosci Lyon, CNRS UMR 5292, F-69003 Lyon, France
[5] Univ Lyon, F-69003 Lyon, France
[6] Univ Lyon 1, F-69003 Lyon, France
关键词
Multiple sclerosis; Genes; Environment; Prevention; Vitamin D; RADIOLOGICALLY ISOLATED SYNDROME; CLINICALLY ISOLATED SYNDROMES; ENVIRONMENTAL RISK-FACTORS; VITAMIN-D INSUFFICIENCY; FOLLOW-UP; DIAGNOSTIC-CRITERIA; OPTIC NEURITIS; PREDICT CONVERSION; MRI CRITERIA; SEX-RATIO;
D O I
10.1016/j.neurol.2012.07.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is the most frequent source of chronic neurological disability in Western countries, and its incidence and prevalence are increasing. However, it is possible to determine its prodromal phase and the radiological, biological and immunological endophenotypes that are present before the clinical onset of the disease, despite remaining unseen with the naked eye. In this context, greater knowledge of the aetiological factors, both genetic and environmental, may lead the way towards primary prevention strategies for MS in the near future. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码:836 / 845
页数:10
相关论文
共 69 条
  • [1] Vitamin D: hope on the horizon for MS prevention?
    不详
    [J]. LANCET NEUROLOGY, 2010, 9 (06) : 555 - 555
  • [2] Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
    Ascherio, Alberto
    Munger, Kassandra L.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (06) : 504 - 513
  • [3] Environmental risk factors for multiple sclerosis. Part I: The role of infection
    Ascherio, Alberto
    Munger, Kassandra L.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (04) : 288 - 299
  • [4] Vitamin D and multiple sclerosis
    Ascherio, Alberto
    Munger, Kassandra L.
    Simon, K. Claire
    [J]. LANCET NEUROLOGY, 2010, 9 (06) : 599 - 612
  • [5] Clinical features and viral serologies in children with multiple a multinational observational study
    Banwell, Brenda
    Krupp, Lauren
    Kennedy, Julia
    Tellier, Raymond
    Tenembaum, Silvia
    Ness, Jayne
    Belman, Anita
    Boiko, Alexei
    Bykova, Olga
    Waubant, Emmanulle
    Kmoh, Jean
    Stoian, Cristino
    Kremenchutzky, Marcelo
    Bardini, Maria Rito
    Ruggieri, Martino
    Rensel, Mary
    Hahn, Renseljin
    Weinstock-Guttman, Bianca
    Yeh, E. Ann
    Farrell, Kevin
    Freedman, Mark
    Livanainen, Matti
    Sevon, Meri
    Bhan, Virender
    Dilenge, Marie-Emmanuelle
    Stephens, Derek
    Bar-Or, Amit
    [J]. LANCET NEUROLOGY, 2007, 6 (09) : 773 - 781
  • [6] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
    Barkhof, F
    Filippi, M
    Miller, DH
    Scheltens, P
    Campi, A
    Polman, CH
    Comi, G
    Ader, HJ
    Losseff, N
    Valk, J
    [J]. BRAIN, 1997, 120 : 2059 - 2069
  • [7] THE EFFECT OF CORTICOSTEROIDS FOR ACUTE OPTIC NEURITIS ON THE SUBSEQUENT DEVELOPMENT OF MULTIPLE-SCLEROSIS
    BECK, RW
    CLEARY, PA
    TROBE, JD
    KAUFMAN, DI
    KUPERSMITH, MJ
    PATY, DW
    BROWN, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (24) : 1764 - 1769
  • [8] Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944
  • [9] The radiologically isolated syndrome Is it very early multiple sclerosis?
    Bourdette, Dennis
    Simon, Jack
    [J]. NEUROLOGY, 2009, 72 (09) : 780 - 781
  • [10] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
    Brex, PA
    Ciccarelli, O
    O'Riordan, JI
    Sailer, M
    Thompson, AJ
    Miller, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) : 158 - 164